Gmp
GreenMedical Packing
Back to NewsRegulatory Updates

EU GMP Annex 1 and Its Implications for Packaging Material Suppliers

2026-06-08

EU GMP Annex 1 and Its Implications for Packaging Material Suppliers

The revised EU GMP Annex 1 places explicit emphasis on a documented contamination control strategy for sterile products. While the annex addresses manufacturing, its expectations ripple upstream to suppliers of primary packaging materials.

What Annex 1 Requires

Annex 1 requires manufacturers of sterile products to establish a contamination control strategy covering all relevant sources of contamination — including incoming materials, components, and packaging. Key themes include:

  • A formally documented and periodically reviewed contamination control strategy
  • Risk-based qualification and monitoring of suppliers
  • Defined controls on material entry into controlled areas
  • Personnel training and gowning appropriate to the area classification
  • Investigation of deviations with defined corrective actions

The practical implication for packaging suppliers is that their own controls become part of a customer's contamination control strategy, and therefore subject to customer audit and documentation requests.

What Customers Now Ask Suppliers

In qualification questionnaires and audits, packaging material customers increasingly request:

  • Particle and bioburden data for materials used in or near sterile areas
  • Cleanroom classification where material is cut, formed, or packed
  • Packaging and handling controls for transport into controlled areas — for example double-bagging procedures
  • Change control commitments covering material, process, and site changes
  • Deviation and complaint handling descriptions, with defined response times

Preparing as a Supplier

Meeting these expectations is largely a documentation and control discipline rather than a materials science problem. The elements that matter most:

1. Documented manufacturing and handling controls at each production step 2. Defined entry procedures for materials into controlled areas 3. Batch-level traceability back to raw material lots 4. A working change control process with defined notification periods 5. A complaint and deviation process with investigation records

Our quality system operates to ISO 15378 principles for primary pharmaceutical packaging, alongside ISO 9001 and our environmental and occupational health and safety certifications — see the certifications page for details.

Practical Advice for Buyers

When qualifying a packaging supplier for a sterile product, ask for the contamination control documentation directly rather than assuming it exists. A supplier that can describe its controls clearly and provide batch-level data will make your own audit and inspection preparation considerably easier.

If you need documentation to support an Annex 1 related supplier qualification, contact our quality team.

Have questions about this topic?

Send your pack format and target market — our technical team replies within 48 hours.

Ask the technical team